This story was originally posted June 4, and updated later that day to include additional information on the project and comment from Alexandria Real Estate Equities' Tom Andrews.

By Alex Philippidis

NEW YORK (GenomeWeb News) — Alexandria Real Estate Equities has won approval from the Planning Board of Cambridge, Mass., to develop a $1 billion, 1.7 million-square-foot complex of office/laboratory space and other uses set to rise over the next several years in the city's East Cambridge section near Kendall Square.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.